Read as article
KATSEYE's 'Animal' Rises Again After 11 Weeks on Charts
By @sharedot · · 7 pages
- K-pop
- Katseye
- Charts
- Spotify
- UK Official Charts
KATSEYE's 'Animal' climbed to No. 48 on Spotify's global chart in week 11, defying the typical K-pop fade.
What Happened: 'Animal' Moves Up, Not Down
The global girl group KATSEYE is showing what The Korea Daily calls "long-term box office power" with 'Animal', the pre-release track from their third EP 'WILD'. According to Spotify's latest weekly chart covering October 2 to 8, 'Animal' climbed two spots to No. The song previously peaked at No. 8 and has now charted for 11 consecutive weeks. In the U.S., the track jumped 12 places to No. 112 on Spotify's Weekly Top Song USA, which both The Korea Daily and Chosunbiz say demonstrates the group's broad fan base and continuous streaming consumption.
Why It Matters: A Reverse of the Usual Chart Fade
K-pop songs typically spike in their debut week and steadily sink as agencies rotate to the next release. A two-spot climb and a 12-spot U.S. leap in week 11 is the opposite pattern, and Chosunbiz frames it as evidence of "lasting box-office strength." The EP title track 'Hootie Frutti' is charting alongside it — No. 150 on Spotify's global weekly list in its eighth consecutive week, after peaking at No. 18. Having two tracks from the same EP simultaneously holding chart positions months after release, rather than a lone lead single, is the specific development fans are pointing to as proof that 'WILD' built a durable audience rather than a moment.
The UK Evidence: Records Beside Taylor Swift
The United Kingdom numbers are where Cineplay finds the milestone. On the Official Singles Top 100 for October 9 to 15, 'Animal' sits at No. 79 in an 11th straight week, and 'Hootie Frutti' is at No. 66 in week eight — figures that corroborate the Spotify story across two chart systems. Cineplay notes 'Animal' reached the group's personal best of No. 12 on that chart, while 'Hootie Frutti' peaked at No. 16. The outlet argues this sustained presence on one of the world's two leading pop charts shows KATSEYE has "moved beyond one-off buzz," standing on the same weekly list as Taylor Swift's 'PATIENT ZERO', which held No. 1 for a second week.
The Stakes: From HYBE-Geffen Project to Pop Mainstay
KATSEYE was launched by HYBE and Geffen Records under chairman Bang Si-hyuk's "multi-home, multi-genre" strategy, debuting in the U.S. in 2024 with what the outlets describe as K-pop methodology applied to a global roster. The results cited across the pack are the stakes' foundation: the EP 'WILD' topped the Billboard 200 — a first for the group, per Cineplay — and three tracks from it entered the Hot 100. As Chosunbiz and The Korea Daily both note, chart endurance in the U.S. and UK simultaneously is the metric that separates a successful global group model from a debut novelty, and KATSEYE is now being read as the test case for that whole strategy.
What Comes Next: Miami, Victoria's Secret, Jingle Ball
The momentum rolls straight into a packed live calendar. Having just wrapped the European dates of THE WILDWORLD TOUR, KATSEYE launches its North American run on October 13 in Miami. For a group whose chart story is about longevity rather than spikes, the year-end event circuit is the next proving ground: sustained visibility through December is what could push 'Animal' past its No.